No channels found
  3. Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer's drug

    Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer's drug

    30
  7. FDA Faulted for Inappropriate Collaboration With Drug Company Before Approving Alzheimer's Drug

    FDA Faulted for Inappropriate Collaboration With Drug Company Before Approving Alzheimer's Drug

    22
    0
    222
    3
  9. FDA approves Alzheimer’s drug Aduhelm, but concerns raised about cost, effectiveness

    FDA approves Alzheimer’s drug Aduhelm, but concerns raised about cost, effectiveness

    26
    1
  10. The Controversial Alzheimer's Drug. Aducanumab (Aduhelm™) has received accelerated approval as a treatment for Alzheimer's disease from the U.S. Food and Drug Administration (FDA).

    The Controversial Alzheimer's Drug. Aducanumab (Aduhelm™) has received accelerated approval as a treatment for Alzheimer's disease from the U.S. Food and Drug Administration (FDA).

    8
  11. FDA Faulted for Inappropriate Collaboration With Drug Company Before Approving Alzheimer's Drug

    FDA Faulted for Inappropriate Collaboration With Drug Company Before Approving Alzheimer's Drug

    34
    1
    332
    1
  12. Three FDA Advisors Resign over Agency's Approval of Shoddy New Alzheimer's Drug

    Three FDA Advisors Resign over Agency's Approval of Shoddy New Alzheimer's Drug

    58
    0
    795
    5
  13. Three FDA Advisors Resign over Agency's Approval of Shoddy New Alzheimer's Drug

    Three FDA Advisors Resign over Agency's Approval of Shoddy New Alzheimer's Drug

    55
    0
    583
    3
  18. FDA TO USE COMPUTER MODELING IN PLACE OF ANIMAL TESTING

    FDA TO USE COMPUTER MODELING IN PLACE OF ANIMAL TESTING

    2
    0
    46
  19. For the First Time, the FDA Has Approved a Researched Alzheimer's Treatment That Shows Promise

    For the First Time, the FDA Has Approved a Researched Alzheimer's Treatment That Shows Promise

    5
    0
    36
    4
  20. The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug _ WSJ

    The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug _ WSJ

    3
    0
    3
  21. FDA Narrows Guidance On New Alzheimer's Drug Amid Criticism

    FDA Narrows Guidance On New Alzheimer's Drug Amid Criticism

    5
    0
    980
    1
  22. DENT Neurologic Institute prepared to move forward with Alzheimer's drug despite controversy

    DENT Neurologic Institute prepared to move forward with Alzheimer's drug despite controversy

    29
  23. What you need to know about the FDA-approved drug for Alzheimer's

    What you need to know about the FDA-approved drug for Alzheimer's

    23
  25. Alzheimer's Disease Amyloid Targeting Meications

    Alzheimer's Disease Amyloid Targeting Meications

    5